Target- |
Mechanism- |
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ Not yet recruitingPhase 2 治疗绝经后骨质疏松症(肾虚精亏证)随机双盲安慰剂对照(以钙剂为基础治疗)多中心的探索性研究
[Translation] A randomized, double-blind, placebo-controlled, multicenter exploratory study on the treatment of postmenopausal osteoporosis (kidney deficiency and sperm deficiency syndrome) (calcium-based treatment)
以钙剂为基础治疗,安慰剂为平行对照,探索太太骨宝颗粒治疗绝经后骨质疏松症(肾虚精亏证)的有效性和安全性,并探讨其临床合适剂量,为本品种进一步的临床试验设计提供临床数据支持。
[Translation] Using calcium as the basic treatment and placebo as a parallel control, this study explores the effectiveness and safety of Taitaigubao Granules in the treatment of postmenopausal osteoporosis (kidney deficiency and sperm deficiency syndrome), and explores its clinically appropriate dosage to provide clinical data support for further clinical trial design of this product.
100 Clinical Results associated with Beijing Sunshine Hehe Traditional Chinese Medicine Technology Development Co., Ltd.
0 Patents (Medical) associated with Beijing Sunshine Hehe Traditional Chinese Medicine Technology Development Co., Ltd.
100 Deals associated with Beijing Sunshine Hehe Traditional Chinese Medicine Technology Development Co., Ltd.
100 Translational Medicine associated with Beijing Sunshine Hehe Traditional Chinese Medicine Technology Development Co., Ltd.